26 research outputs found

    Morphine and Clonidine Synergize to Ameliorate Low Back Pain in Mice

    Get PDF
    Chronic low back pain (LBP) is a debilitating condition associated with signs of axial and radiating pain. In humans with chronic LBP, opioids are often prescribed with varying outcomes and a multitude of side effects. Combination therapies, in which multiple pharmacological agents synergize to ameliorate pain without similar potentiation of adverse reactions, may be useful in improving therapeutic outcome in these patients. The SPARC-null mouse model of low back pain due to disc degeneration was used to assess the effects of opioid (morphine) and α2-adrenergic agonist (clonidine) coadministration on measures of axial and radiating pain. The results indicate that systemic morphine and clonidine, coadministered at a fixed dose of 100 : 1 (morphine : clonidine), show a synergistic interaction in reversing signs of axial LBP, in addition to improving the therapeutic window for radiating LBP. Furthermore, these improvements were observed in the absence of synergy in assays of motor function which are indicative of side effects such as sedation and motor incoordination. These data show that the addition of low-dose systemic clonidine improves therapeutic outcome in measures of both axial and radiating pain. Combination therapy could be of enormous benefit to patients suffering from chronic LBP

    Morphine and Clonidine Synergize to Ameliorate Low Back Pain in Mice

    Full text link
    Chronic low back pain (LBP) is a debilitating condition associated with signs of axial and radiating pain. In humans with chronic LBP, opioids are often prescribed with varying outcomes and a multitude of side effects. Combination therapies, in which multiple pharmacological agents synergize to ameliorate pain without similar potentiation of adverse reactions, may be useful in improving therapeutic outcome in these patients. The SPARC-null mouse model of low back pain due to disc degeneration was used to assess the effects of opioid (morphine) andα2-adrenergic agonist (clonidine) coadministration on measures of axial and radiating pain. The results indicate that systemic morphine and clonidine, coadministered at a fixed dose of 100 : 1 (morphine : clonidine),show a synergistic interaction in reversing signs of axial LBP, in addition to improving the therapeutic window for radiating LBP.Furthermore, these improvements were observed in the absence of synergy in assays of motor function which are indicative of side effects such as sedation and motor incoordination. These data show that the addition of low-dose systemic clonidine improves therapeutic outcome in measures of both axial and radiating pain. Combination therapy could be of enormous benefit to patients suffering from chronic LBP

    Peripheral Nerve Injury Is Associated with Chronic, Reversible Changes in Global DNA Methylation in the Mouse Prefrontal Cortex

    Get PDF
    Changes in brain structure and cortical function are associated with many chronic pain conditions including low back pain and fibromyalgia. The magnitude of these changes correlates with the duration and/or the intensity of chronic pain. Most studies report changes in common areas involved in pain modulation, including the prefrontal cortex (PFC), and pain-related pathological changes in the PFC can be reversed with effective treatment. While the mechanisms underlying these changes are unknown, they must be dynamically regulated. Epigenetic modulation of gene expression in response to experience and environment is reversible and dynamic. Epigenetic modulation by DNA methylation is associated with abnormal behavior and pathological gene expression in the central nervous system. DNA methylation might also be involved in mediating the pathologies associated with chronic pain in the brain. We therefore tested a) whether alterations in DNA methylation are found in the brain long after chronic neuropathic pain is induced in the periphery using the spared nerve injury modal and b) whether these injury-associated changes are reversible by interventions that reverse the pathologies associated with chronic pain. Six months following peripheral nerve injury, abnormal sensory thresholds and increased anxiety were accompanied by decreased global methylation in the PFC and the amygdala but not in the visual cortex or the thalamus. Environmental enrichment attenuated nerve injury-induced hypersensitivity and reversed the changes in global PFC methylation. Furthermore, global PFC methylation correlated with mechanical and thermal sensitivityin neuropathic mice. In summary, induction of chronic pain by peripheral nerve injury is associated with epigenetic changes in the brain. These changes are detected long after the original injury, at a long distance from the site of injury and are reversible with environmental manipulation. Changes in brain structure and cortical function that are associated with chronic pain conditions may therefore be mediated by epigenetic mechanisms

    Overlapping Signatures of Chronic Pain in the DNA Methylation Landscape of Prefrontal Cortex and Peripheral T Cells

    Full text link
    We tested the hypothesis that epigenetic mechanisms in the brain and the immune system are associated with chronic pain. Genome-wide DNA methylation assessed in 9 months post nerve-injury (SNI) and Sham rats, in the prefrontal cortex (PFC) as well as in T cells revealed a vast difference in the DNA methylation landscape in the brain between the groups and a remarkable overlap (72%) between differentially methylated probes in T cells and prefrontal cortex. DNA methylation states in the PFC showed robust correlation with pain score of animals in several genes involved in pain. Finally, only 11 differentially methylated probes in T cells were sufficient to distinguish SNI or Sham individual rats. This study supports the plausibility of DNA methylation involvement in chronic pain and demonstrates the potential feasibility of DNA methylation markers in T cells as noninvasive biomarkers of chronic pain susceptibility

    The relationship between mesocerebral activity and sexual arousal in the snail, «Cornu aspersum»

    No full text
    The courtship behavior of the pulmonate snail Cornu aspersum comprises an intricate sequence of acts followed by dart shooting. This study aims at comparing mesocerebral electrical activity in ganglia removed from snails belonging to three stages of sexual arousal: Non-excited snails, pre dart shooters, and post dart shooters. The groups were compared using measurements of spontaneous mesocerebral activity and responses to simultaneous stimulation of six nerves. Dart shooters showed the highest spontaneous activity, followed by the pre dart shooters and finally, non-excited snails. Nerve stimulation increased activity only in non-excited snails. Cluster analysis failed to show a significant change in the number of active units before and after nerve stimulation. These results show that mesocerebral activity is correlated with the behavioral stages of courtship, and is influenced by input from the stimulated nerves, thus linking the ethology and physiology of mating in this species.Le comportement d'accouplement de l'escargot pulmonate, soit la Cornu aspersum, est composĂ© d'un rituel Ă©tablit suivi du lancement du dard. Cet Ă©tude vise Ă  faire une Ă©tude comparative entre les diffĂ©rent niveaux d'activitĂ© Ă©lectrique mĂ©socĂ©rĂ©brale perçus dans les ganglions extrait d'escargots ayant atteint l'un des trois niveaux d'excitation sexuelle, soit les escargots: non-excitĂ©s, prĂ©-lanceurs de dards et post-lanceur de dards. De ces Ă©chantillons, le niveau spontanĂ© d'activitĂ© mĂ©socĂ©rĂ©brale et l'effet de la stimulation simultanĂ©es de six nerfs ont Ă©tĂ© comparĂ©s. L'Ă©chantillon composĂ© des post-lanceurs de dards ont dĂ©montrĂ© des niveaux spontanĂ© d'activitĂ© mĂ©socĂ©rĂ©brale les plus Ă©levĂ©s parmi les trois; les Ă©chantillons composĂ© de prĂ©-lanceurs de dards et d'escargots non-excitĂ©s ont dĂ©montrĂ©s des niveaux respectivement infĂ©rieurs Ă  celle-ci. Alternativement, les stimulant nerveux augmentent uniquement l'activitĂ© mĂ©socĂ©rĂ©brale des escargots non-excitĂ©s. MalgrĂ© ces indicatifs statistiquement significatif, l'analyse de groupement a Ă©chouer Ă  la tĂąche d'identification d'un changement significatif d'unitĂ©s actives avant et aprĂšs la stimulation nerveuse. Ces rĂ©sultats dĂ©montrent qu'il y a effectivement un corrĂ©lation entre l'activitĂ© mĂ©socĂ©rĂ©brale et les diffĂ©rents comportements d'accouplement associĂ© a chacun des niveau d'excitation; en plus d'ĂȘtre affectĂ© par l'influx sensoriel provenant des nerfs stimulĂ©s, ainsi liant l'ethologie et la physiologie au processus d'accouplement de l'espĂšce

    The SPARC-null mouse model of low back pain: Mechanism, Treatment, and Translation to Humans

    No full text
    Persistent low back pain (LBP) is the most common form of chronic illness in Canadians age 60 and under, affecting 15% of the population. In addition to being a major health problem, it also has serious economic consequences. Current diagnostic and therapeutic approaches to chronic back pain are limited by our narrow understanding of the underlying biological mechanisms. As a consequence, treatment is not always effective and individuals may suffer for years without relief. LBP is often associated with signs of degeneration in the intervertebral discs. LBP encompasses a wide spectrum of pain disorders including axial pain in the back region and radiating pain down one or both legs. This thesis investigates the mechanisms and treatment of axial and radiating pain associated with disc degeneration (DD) in a transgenic mouse model and in human subjects. SPARC-null mice show anatomical signs of disc degeneration and behavioral signs of pain and are thus a valid model of LBP due to DD.Our results show that loss of lumbar disc height correlates with radiating pain in mice. In addition, we show that axial pain and radiating pain have different pharmacological profiles, suggesting the involvement of different mechanisms. Furthermore, we explore the use of opioid-adrenergic combination therapy to improve therapeutic outcome in our model. Finally, we propose an epigenetic mechanism governing SPARC expression, disc degeneration, and back pain in aging wild-type mice and in human subjects with LBP.The results shown in this thesis will serve to increase our understanding of the mechanisms of pain due to DD. This mechanism-based approach is key in improving therapeutic options for the millions of patients suffering from chronic low back pain.La douleur persistante du bas du dos (lombalgie) est la forme la plus commune des maladies chroniques chez les Canadiens de 60 ans et moins, touchant 15% de la population. En plus d'ĂȘtre un problĂšme majeur de santĂ©, la lombalgie a Ă©galement de graves consĂ©quences Ă©conomiques. Les approches actuelles de diagnostic et de traitement de la lombalgie chronique sont limitĂ©es par notre comprĂ©hension limitĂ©e des mĂ©canismes biologiques sous-jacents et la prise en charge n'est pas toujours efficace. Ainsi, les patients peuvent souffrir pendant de trĂšs longues pĂ©riodes de temps sans soulagement. La lombalgie est souvent associĂ©e avec des signes de dĂ©gĂ©nĂ©rescence des disques intervertĂ©braux. Elle englobe un large Ă©ventail de dĂ©sordres douleureux et peut ĂȘtre sub-divisĂ©e en douleur axiale (dans la rĂ©gion du dos) et/ou douleur radiculaire (le long d'une jambe ou deux). Cette thĂšse Ă©tudie les mĂ©canismes et le traitement des douleurs axiales et radiculaires associĂ©es Ă  la dĂ©gĂ©nĂ©rescence des disques (DD) dans un modĂšle murin transgĂ©nique et chez des sujets humains. Les souris SPARC-nul montrent simultanĂ©ment des signes anatomiques de dĂ©gĂ©nĂ©rescence des disques intervertĂ©braux et des signes comportementaux de douleur. Ces souris reprĂ©sentent donc un modĂšle valide de lombalgie due Ă  la dĂ©gĂ©nĂ©rescence des disques.Nos rĂ©sultats prouvent que la perte de hauteur des disques lombaires corrĂšle avec le dĂ©veloppement de douleur radiculaire chez la souris. En outre, les douleurs axiales et radiculaires prĂ©sentent des profils pharmacologiques diffĂ©rents, suggĂšrant l'implication de mĂ©canismes diffĂ©rents. Dans notre modĂšle, nous explorons Ă©galement l'utilisation d'une thĂ©rapie combinant des traitements opiacĂ©s et adrĂ©nergiques pour amĂ©liorer des rĂ©sultats thĂ©rapeutiques. Finalement, nous proposons un mĂ©canisme Ă©pigĂ©nĂ©tique rĂ©gissant l'expression de SPARC, la dĂ©gĂ©nĂ©rescence des disques, et la lombalgie chez des souris sauvages agĂ©es et des sujets humains. Nous croyons que les rĂ©sultats prĂ©sentĂ©s dans cette thĂšse serviront Ă  amĂ©liorer notre connaissance des mĂ©canismes de la douleur liĂše Ă  la dĂ©gĂ©nĂ©rescence des disques intervertĂ©braux. Une telle approche mĂ©canistique permettra d'augmenter les options thĂ©rapeutiques pour des millions de patients souffrant de douleur lombo-sacrĂ©e chronique.

    Nonpharmacological Interventions in Targeting Pain-Related Brain Plasticity

    No full text
    Chronic pain is a highly prevalent and debilitating condition that is frequently associated with multiple comorbid psychiatric conditions and functional, biochemical, and anatomical alterations in various brain centers. Due to its widespread and diverse manifestations, chronic pain is often resistant to classical pharmacological treatment paradigms, prompting the search for alternative treatment approaches that are safe and efficacious. The current review will focus on the following themes: attentional and cognitive interventions, the role of global environmental factors, and the effects of exercise and physical rehabilitation in both chronic pain patients and preclinical pain models. The manuscript will discuss not only the analgesic efficacy of these therapies, but also their ability to reverse pain-related brain neuroplasticity. Finally, we will discuss the potential mechanisms of action for each of the interventions
    corecore